Washington, Sep 27, 2025

Bhaskar Chakravorti, the Dean of Global Business at The Fletcher School of Law and Diplomacy at Tufts University, said that Trump’s decision to impose 100 per cent tariffs on pharmaceuticals won’t impact India, at least for now.

In an exclusive interview with IANS on Friday, Chakravorti argued that he wouldn’t “rule out” tariffs on Indian generic pharmaceuticals in future.

“This specific move to put tariffs on patented pharmaceuticals is not something that is directly going to affect the Indian manufacturers as much, but it’s coming awfully close. So, I wouldn’t rule it out that somewhere down the road, tariffs on generic pharmaceuticals as well,” he added.

US President Donald Trump announced on Thursday that any patented or branded pharmaceutical products will

See Full Page